内皮型一氧化氮合酶基因转染促进内皮祖细胞移植对大鼠颈动脉新生内膜增生的抑制作用Endothelial nitric oxide synthase gene transfection enhances anti-proliferative effect of EPCs on injured artery
崔斌,丁小涵,赵刚,宋明宝,于世勇,陈剑飞,黄岚
摘要(Abstract):
目的探讨内皮型一氧化氮合酶(eNOS)基因修饰的内皮祖细胞(EPCs)移植对大鼠颈动脉球囊损伤后新生内膜增生的影响。方法将携带eNOS基因的逆转录病毒载体pMCVeNOS或携带绿荧光蛋白(GFP)的空病毒载体pMCV-GFP分别转染体外培养的EPCs,得到pMCV-eNOS-EPCs和pMCV-GFP-EPCs。分别将转染的pMCV-eNOS-EPCs、pMCV-GFP-EPCs或生理盐水从尾静脉移植至颈动脉内皮损伤大鼠模型。术后14 d采用逆转录-聚合酶链反应(RT-PCR)、蛋白质印迹法、免疫组织化学及苏木素-伊红(HE)染色方法进行检测。结果 eNOS-EPCs组eNOS信使RNA(mRNA)及蛋白表达水平较GFP-EPCs组及对照组显著增高。与对照组比较,球囊损伤后14 d EPCs移植可显著抑制新生内膜的过度增殖,血管腔狭窄程度显著减轻[eNOS-EPCs组(0.58±0.05)比对照组(1.56±0.21),P<0.01;GFP-EPCs组(0.84±0.09)比对照组,P<0.01]。eNOS过表达可进一步增强EPCs的抗增殖效应[eNOS-EPCs组(0.58±0.05)比GFP-EPCs组(0.84±0.09),P<0.05],显著改善内皮依赖性血管舒张反应。结论 eNOS基因修饰可有效促进EPCs对损伤血管内膜的抗增殖作用,显著改善血管内皮功能。
关键词(KeyWords): 内皮型一氧化氮合酶;基因转染;内皮祖细胞;移植;新生内膜
基金项目(Foundation): 国家自然科学基金资助项目(81100149)
作者(Author): 崔斌,丁小涵,赵刚,宋明宝,于世勇,陈剑飞,黄岚
参考文献(References):
- [1]Alfonso F,Byrne RA,Rivero F,et al.Current treatment of In-stent restenosis.J Am Coll Cardiol,2014,63:2659-2673.
- [2]Asahara T,Murohara T,Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenensis.Science,1997,275:964-967.
- [3]Kalka C,Macuda H,Takahashi T,et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.Proc Natl Acad Sci U S A,2000,97:3422-3427.
- [4]Bakogiannis C,Tousoulis D,Androulakis E,et al.Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.Curr Med Chem,2012,19:2597-2604.
- [5]Kotlinowski J,Dulak J,Józkowicz A.Type 2 diabetes mellitus impairs endothelial progenitor cells functions.PostepyBiochem,2013,59:257-266.
- [6]Ulrich F,Thomas M.Endothelial nitric oxide synthase in vascular disease.Circulation,2006,113:1708-1714.
- [7]Hamed S,Brenner B,Roguin A.Nitric oxide:a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2.Cardiovasc Res,2011,91:9-15.
- [8]Kong D,Melo LG,Mangi AA,et al.Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.Circulation,2004,109:1769-1775.
- [9]崔斌,黄岚,武晓静,等.内皮祖细胞移植对血管内膜修复的影响.中国病理生理杂志,2007,23:625-628.
- [10]崔斌,黄岚,宋耀明,等.冠心病患者心局部血管内皮生长因子的检测及临床意义.中国介入心脏病学杂志,2005,13:380-382.
- [11]李德,何国祥,唐波,等.BTEB2反义基因转染对大鼠颈动脉球囊损伤后内皮修复的影响.中国介入心脏病学杂志,2005,13:319-321.
- [12]Padfield GJ,Newby DE,Mills NL.Understanding the role of endothelial progenitor cells in percutaneous coronary intervention.J Am Coll Cardiol,2010,55:1553-1565.
- [13]Zhang Y,Janssens SP,Wingler K,et al.Modulating endothelial nitric oxide synthase:a new cardiovascular therapeutic strategy.Am J Physiol Heart CircPhysiol,2011,301:H634-H646.